Loading...
Book a Meeting

Golgi Apparatus Glycosylation Detection Service

Introduction Key Workflow Applications FAQs

Do you currently find yourself grappling with prolonged drug development cycles? Our Golgi apparatus glycosylation detection service helps you accelerate drug discovery and develop highly specific antibodies through advanced mass spectrometry and innovative glycomic profiling techniques. We promise to deliver precise, high-quality data to streamline your research.

Introduction of Golgi Apparatus Glycosylation Detection

The Golgi apparatus organizes a complex array of glycosyltransferases and other enzymes that add and modify sugar chains (glycans) onto proteins. The fidelity of this process is paramount, as defects in glycosylation are directly linked to a wide range of human diseases. Our service provides a deep molecular understanding of these processes, which is essential for advancing research in drug discovery and diagnostics.

GOLPH3 modulates Golgi-resident protein glycosylation patterns. (OA Literature)Fig.1 GOLPH3's role in Golgi protein glycosylation. 1

Key Workflow

  • Sample Preparation and Golgi Enrichment
    We begin by isolating the Golgi apparatus from your provided cell or tissue sample. This is followed by a rigorous purification step to ensure we are focusing on the organelles of interest. For purified proteins, this step is streamlined.
  • Glycoprotein Enrichment and Digestion
    Once the Golgi fraction is isolated, we use advanced methods to enrich for glycoproteins. These are then digested to obtain the individual glycans or glycopeptides, preparing them for analysis.
  • Mass Spectrometry (MS) Analysis
    Using cutting-edge, high-resolution mass spectrometers, we perform an in-depth analysis of the glycan fragments. Our instruments are capable of detecting a wide range of glycan structures with high sensitivity and accuracy.
  • Bioinformatics and Data Analysis
    The raw data from the mass spectrometer is processed using advanced bioinformatics pipelines. This step involves identifying glycan compositions, determining linkage patterns, and quantifying their relative abundance.
  • Delivering the Final Report
    We consolidate all research findings into a complete analytical report with actionable insights. This includes a detailed breakdown of glycan profiles, data interpretation, and a clear summary of the results.

Applications

  • Drug Discovery and Development

Glycosylation analysis is critical for developing new therapeutic proteins, including monoclonal antibodies and fusion proteins. Our service helps to ensure the quality, stability, and efficacy of biopharmaceuticals.

  • Biomarker Discovery

Aberrant glycosylation patterns are closely linked to various diseases, including cancer and congenital disorders of glycosylation (CDG). We can help researchers identify and validate novel glycan biomarkers for early disease detection and prognosis.

  • Fundamental Biological Research

Understanding the precise functions of the Golgi apparatus and its role in glycosylation is essential for cell biology. Our service provides detailed insights into protein trafficking, cellular signaling, and other key biological processes.

  • Quality Control in Bioproduction

For companies producing recombinant proteins, monitoring glycosylation is a key quality control step. Our service provides the detailed data needed to ensure batch-to-batch consistency and regulatory compliance.

FAQs

Q: What types of glycosylation can your service analyze?

A: Our service can perform a comprehensive analysis of various glycosylation types, including N-glycosylation and O-glycosylation. We can also handle the analysis of glycolipids and other complex glycoconjugates.

Q: How does your service compare to general proteomics analysis?

A: While general proteomics provides a wealth of information on protein expression, it often overlooks the fine details of glycosylation. Our specialized service goes beyond protein identification to provide detailed glycan structural analysis, which is crucial for understanding protein function and identifying disease-specific biomarkers.

Q: What kind of sample quantity do I need to provide?

A: The required sample quantity can vary depending on your specific project and the complexity of your sample. We encourage you to contact us to discuss your project needs, and our experts will provide a tailored recommendation to ensure optimal results.

Q: Can this service be used for biopharmaceutical development?

A: Absolutely. Glycosylation is a key quality attribute for biopharmaceuticals. Our service is ideal for characterizing the glycan profiles of therapeutic proteins, ensuring product quality, stability, and efficacy.

Q: What if my sample is from a non-standard source?

A: Our experienced team has a proven track record of working with diverse sample types, from cell lines to tissue biopsies. We pride ourselves on our ability to customize our workflow to meet the unique challenges of your research. Please reach out to us to discuss your specific sample type.

To learn more about how our services can help your project, please visit our website or contact us directly.

Reference

  1. Bucurica, Sandica, et al. "Golgi apparatus target proteins in gastroenterological cancers: a comprehensive review of GOLPH3 and golga proteins." Cells 12.14 (2023): 1823. DOI: 10.3390/cells12141823. Distributed under Open Access license CC BY 4.0, without modification.
For Research Use Only. We do not provide direct services or products for patients.
Online Inquiry
For Research Use Only. We do not provide direct services or products for patients.
Contact Us

(USA)
(UK)
(Germany)

Inquiry